Ketamine alleviates NMDA receptor hypofunction through synaptic trapping
Neuron · 2024
DOI: 10.1016/j.neuron.2024.06.028 ↗Kurz gefasst
Fachartikel in der Zeitschrift Neuron, 2024. Verfasst von Frédéric Villéga und 14 weiteren Autor:innen. Beteiligte Einrichtung: University of Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS UMR 5297, 33000 Bordeaux, France; Department of Pediatric Neurology,…. Hauptthemen laut MEDLINE: Ketamine, Receptors, N-Methyl-D-Aspartate, Synapses, Autoantibodies. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fondation FondaMental, Agence Nationale de la Recherche, Fondation pour la Recherche Médicale.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- University of Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS UMR 5297, 33000 Bordeaux, France; Department of Pediatric Neurology, CIC-1401, University Children's Hospital of Bordeaux, Bordeaux, Franc…
- University of Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS UMR 5297, 33000 Bordeaux, France.
- Synaptopathies and Autoantibodies Team, Institut NeuroMyoGene-MeLis, INSERM U1314, CNRS UMR 5284, Université Claude Bernard Lyon1, 69373 Lyon, France; French Reference Centre on Paraneoplastic Neurological Syndromes and…
- University of Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS UMR 5297, 33000 Bordeaux, France. Electronic address: julien.dupuis@u-bordeaux.fr.
- University of Bordeaux, CNRS, Interdisciplinary Institute for Neuroscience, IINS UMR 5297, 33000 Bordeaux, France. Electronic address: laurent.groc@u-bordeaux.fr.
Förderung
- Fondation FondaMental
- Agence Nationale de la Recherche
- Fondation pour la Recherche Médicale
- Conseil Régional Aquitaine
- Institut National de la Santé et de la Recherche Médicale
- Université de Bordeaux
- European Research Council
- Human Frontier Science Program
Zitieren
APA
Villéga, F., Fernandes, A., Jézéquel, J., Uyttersprot, F., Benac, N., Zenagui, S., Bastardo, L., Gréa, H., Bouchet, D., Villetelle, L., Nicole, O., Rogemond, V., Honnorat, J., Dupuis, J. P., & Groc, L. (2024). Ketamine alleviates NMDA receptor hypofunction through synaptic trapping. Neuron. https://doi.org/10.1016/j.neuron.2024.06.028
Vancouver
Villéga F, Fernandes A, Jézéquel J, Uyttersprot F, Benac N, Zenagui S, et al. Ketamine alleviates NMDA receptor hypofunction through synaptic trapping. Neuron. 2024. doi:10.1016/j.neuron.2024.06.028
BibTeX
@article{Villga2024,
author = {Villéga, Frédéric and Fernandes, Alexandra and Jézéquel, Julie and Uyttersprot, Floriane and Benac, Nathan and Zenagui, Sarra and Bastardo, Laurine and Gréa, Hélène and Bouchet, Delphine and Villetelle, Léa and Nicole, Olivier and Rogemond, Véronique and Honnorat, Jérôme and Dupuis, Julien P and Groc, Laurent},
title = {Ketamine alleviates NMDA receptor hypofunction through synaptic trapping},
journal = {Neuron},
year = {2024},
doi = {10.1016/j.neuron.2024.06.028}
}
EUVIMED